Strikingly, TERT promoter mutations are not unique to melanomas, but have been later found to be frequent in many other malignancies such as hepatocellular carcinoma, bladder cancer, and glioblastoma [13,14,15,16,17,18,19]. Here, TERT is linked to melanoma.